Skip to Main content Skip to Navigation
Journal articles

PET imaging in patients with meningioma—report of the RANO/PET Group

Norbert Galldiks 1, 2, 3, 4 Nathalie Albert 5 Michael Sommerauer 6, 7 Anca Grosu 8 Ute Ganswindt 5 Ian Law 9 Matthias Preusser 10 Emilie Le Rhun 11 Michael Vogelbaum 12 Gelareh Zadeh 13 Frédéric Dhermain 14 Michael Weller 1 Karl-Josef Langen 2, 15 Jörg Tonn 5, 16, 17
1 University Hospital of Cologne [Cologne]
2 Research Center Juelich [Juelich, Germany]
3 University of Cologne
4 University of Bonn
5 LMU - Ludwig-Maximilians-Universität München
6 University hospital of Zurich [Zurich]
7 Aarhus University Hospital
8 University Hospital Freiburg
9 IT University of Copenhagen
10 Medizinische Universität Wien = Medical University of Vienna
11 CHRU Lille - Centre Hospitalier Régional Universitaire [Lille]
12 Cleveland Clinic
13 Toronto Western Hospital
14 IGR - Institut Gustave Roussy
15 UKA - Universitätsklinikum RWTH Aachen - University Hospital Aachen [Aachen, Germany]
16 Partner Sites - German Cancer Consortium [Freiburg, Germany]
17 Partner Sites - German Cancer Consortium [Munich, Germany]
Abstract : Meningiomas are the most frequent nonglial primary brain tumors and represent about 30% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly MRI or, rarely, CT. Most common treatment options are neurosurgical resection and radiotherapy (eg, radiosurgery, external fractionated radiotherapy). For follow-up after treatment, a structural imaging technique such as MRI or CT is used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as PET can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.
Keywords : MRI ligand meningiomas positron emission tomography somatostatin
Document type :
Journal articles
Complete list of metadata

Cited literature [79 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-02940559
Contributor : Michel Salzet Connect in order to contact the contributor
Submitted on : Wednesday, September 16, 2020 - 1:20:07 PM
Last modification on : Friday, October 23, 2020 - 3:06:59 PM
Long-term archiving on: : Thursday, December 3, 2020 - 8:10:13 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

INSERM | FNCLCC | IGR

Citation

Norbert Galldiks, Nathalie Albert, Michael Sommerauer, Anca Grosu, Ute Ganswindt, et al.. PET imaging in patients with meningioma—report of the RANO/PET Group. Neuro-Oncology, Oxford University Press (OUP), 2017, 19 (12), pp.1576-1587. ⟨10.1093/neuonc/nox112⟩. ⟨inserm-02940559⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

124